Dr. Joseph is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16311 Ventura Blvd
Suite 835
Encino, CA 91436Phone+1 818-616-3880
Summary
- Dr. John Joseph is the director of the Clinical Testing of Beverly Hills. This research facility is located in Encino, CA. He received his medical degree from University of Illinois College of Medicine and completed his residency in Head and Neck surgery from the University of Iowa scoring in the top 3 % on his board examination. He also completed a fellowship in Facial Plastic surgery and is double Board Certified. He has been in practice 35 years. His practice is primarily clinical research but also treats patients in the aesthetic area of the face.
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Otolaryngology - Head and Neck Surgery, 1982 - 1987
- University of Illinois College of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 1986 - 2026
- IA State Medical License 1983 - 1987
- IL State Medical License 1985 - 1987
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Clinical Trials
- Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation Start of enrollment: 2008 Mar 01
- Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation Start of enrollment: 2008 Oct 01
- Ultherapy® for the Treatment of Acne Scars Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsHigh-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice.Sabrina G. Fabi, Jean Carruthers, John H Joseph, Sue Ellen Cox, Steve Yoelin
Aesthetic Surgery Journal. Open Forum. 2021-09-19 - 12 citationsSafety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines.John H Joseph, Corey Maas, Melanie D Palm, Edward Lain, Dee Anna Glaser
Aesthetic Surgery Journal. 2022-10-13 - 6 citationsThe Case for Synthetic InjectablesJohn H Joseph
Facial Plastic Surgery Clinics of North America. 2015-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: